HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


REV: Revlon Cl A New - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
REVLON CL A NEW (NYSE)
REV 17.78 -0.13 (-0.73%) Vol.  184,437 14:21 ET
Revlon, Inc. conducts its business exclusively through its subsidiary, Revlon Consumer Products Corp. and its subsidiaries. They manufacture, market and sell an extensive array of cosmetics and skin care,fragrances and personal care products. Their brand names are REVLON, COLORSTAY, REVLON AGE DEFYING, ALMAY and ULTIMA II in cosmetics; MOON DROPS, ETERNA 27, ULTIMA II and JEANNE GATINEAU in skin care; CHARLIE and FIRE & ICE in fragrances; and FLEX, OUTRAGEOUS, MITCHUM, COLORSTAY, COLORSILK, JEAN NATE, PLUSBELLE, BOZZANO and COLORAMA in personal care.

 General Information
REVLON INC-A
237 Park Avenue
New York, NY 10017
Phone: 212 527-4000
Fax: 212 527-4130
Web: www.revlon.com
Email: None
 
Industry COSMETICS&TLTRS
Sector: Consumer Staples
 
Fiscal Year End December
Last Reported Quarter 09/30/09
Next EPS Date 02/11/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 17.91
52 Week High 18.45
52 Week Low 2.30
Beta 1.69
20 Day Moving Average 1,120,363.88
Target Price Consensus 21
 
 % Price Change
4 Week 202.53
12 Week 311.72
YTD 168.52
 % Price Change Relative to S&P 500
4 Week 190.98
12 Week 271.65
YTD 113.67
 Share Information
Shares Outstanding (millions) 51.57
Market Capitalization (millions) 923.58
Short Ratio 2.47
Last Split Date 09/16/2008
 Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate N/A
Current Year EPS Consensus Estimate 1.05
Estimated Long-Term EPS Growth Rate -
Next EPS Report Date 02/11/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 1.00
30 Days Ago 3.00
60 Days Ago 3.00
90 Days Ago 3.00

 Fundamental Ratios
 P/E
Current FY Estimate: 17.06
Trailing 12 Months: 15.18
PEG Ratio -
 EPS Growth
vs. Previous Year 246.67%
vs. Previous Quarter 25.71%
 Sales Growth
vs. Previous Year -2.45%
vs. Previous Quarter: 1.37%
 Price Ratios
Price/Book -
Price/Cash Flow 9.50
Price / Sales 0.72
 ROE
09/30/09 -
06/30/09 -
03/31/09 -
 ROA
09/30/09 7.61
06/30/09 2.79
03/31/09 2.92
 Current Ratio
09/30/09 1.33
06/30/09 1.27
03/31/09 1.35
 Quick Ratio
09/30/09 0.90
06/30/09 0.82
03/31/09 0.84
 Operating Margin
09/30/09 4.73
06/30/09 1.76
03/31/09 1.82
 Net Margin
09/30/09 3.56
06/30/09 0.56
03/31/09 2.69
 Pre-Tax Margin
09/30/09 3.56
06/30/09 0.56
03/31/09 2.69
 Book Value
09/30/09 -20.23
06/30/09 -20.85
03/31/09 -21.25
 Inventory Turnover
09/30/09 3.16
06/30/09 3.00
03/31/09 2.89
 Debt-to-Equity
09/30/09 -1.20
06/30/09 -1.18
03/31/09 -1.18
 Debt to Capital
09/30/09 -
06/30/09 -
03/31/09 -

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research